Skip to content

Author

Constanze Schmidt

We have 5 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Investigating the TASK1 potassium channel in equine atrial myocardium as a potential treatment target for atrial fibrillation.

BACKGROUND AND PURPOSE Atrial fibrillation (AF) is the most common clinically relevant arrhythmia in horses, with limited pharmacological treatment options in both veterinary and human medicine. TASK1 potassium channels represent a promising atrial-selective antiarrhythmic target, but their relevance in horses has not...

Lize-Maria Verhaeghe, N. Jávorszky, M. Kraft et al. · 0 citations
Open access Sep 2026

Comparative Analysis of Atrial Electrophysiology Across Animal Species and Humans: Enhancing Translation in Atrial Arrhythmia Research.

This study provides a reference for species-specific atrial action potential characteristics, linking functional properties to transcriptomic ion channel expression, and demonstrates that relative changes in action potential parameters can be inferred from transcriptomic data using in silico simulations.

A. Paasche, F. Wiedmann, C. Goetz et al. · 0 citations
Review Open access Oct 2026

Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine

This review provides an overview of recent advances in the development of multitarget drugs (MTDs) for cardiac diseases, with a particular focus on emerging molecular scaffolds and their pharmacological properties. We discuss the fundamental principles of cardiac polypharmacology and multitarget drug design, highlighti...

G. Y. Mitronova, V. Belov, Constanze Schmidt et al. · 0 citations
Open access Jul 2026

SGLT2 inhibition improves sarcomere contractile dysfunction in human models of dilated cardiomyopathy

It is found that a subcellular signaling pathway dysregulated in DCM CMs, clathrin-mediated endocytosis (CME)-dependent signaling, may be recovered by EMP treatment in DCM TPM1-L185F iPSC-CMs, which supports that EMP modulates aspects of CME-signaling, and contributes to restored sarcomere functions.

Daria Plota, H. N. Saleem, K. Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.